The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Artificial Intelligence (AI) In Respiratory Diseases Market Expected To Change Between 2026 And 2030?

The artificial intelligence (AI) in respiratory diseases market size has experienced consistent expansion over recent years. This market is projected to expand from $7.98 billion in 2025 to $8.38 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. Historically, this growth has been driven by several factors, including the increasing occurrence of respiratory diseases, a greater reliance on CT and MRI imaging, the ongoing digitalization of healthcare records, the early integration of AI-assisted diagnostics, and the enhancement of hospital diagnostic capacities.

The market size for artificial intelligence (AI) in respiratory diseases is projected to experience robust expansion over the coming years. This market is predicted to reach $10.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the forecast period include a rising demand for tailored respiratory care, enhanced integration of AI with clinical decision support systems, the widening scope of remote monitoring for individuals with chronic respiratory conditions, an increasing emphasis on preventive pulmonology, and progress in medical imaging AI. Key trends anticipated within the forecast timeframe encompass the increasing utilization of AI-driven imaging analysis, the growing acceptance of predictive models for disease progression, the broader incorporation of AI into pulmonary diagnostics, the proliferation of remote respiratory monitoring technologies, and a heightened emphasis on identifying diseases early.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

What Drivers Are Expected To Influence The Artificial Intelligence (AI) In Respiratory Diseases Market During The Forecast Period?

The respiratory disease market is influenced by various factors. Environmental pollution refers to the introduction of any substance or energy into the environment at a rate faster than it can be dispersed or stored in a harmless form. Artificial intelligence (AI) in respiratory diseases has the capability to substantially reduce the effects of environmental pollution on respiratory health by providing real-time monitoring, individualized risk assessments, data-driven decision-making, and innovative solutions for both individuals and communities. For example, in November 2024, according to the Global Carbon Budget, a Japan-based annual scientific assessment, fossil carbon dioxide emissions climbed to 37.4 billion tonnes, an increase of 0.8% over the previous year. Therefore, growing environmental pollution is a key factor driving the growth of artificial intelligence (AI) in the respiratory disease market.

How Is The Artificial Intelligence (AI) In Respiratory Diseases Market Structured Across Different Segments?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

How Are Trends Impacting The Artificial Intelligence (AI) In Respiratory Diseases Market?

Leading companies in the artificial intelligence (AI) domain within the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients’ tidal breathing. The n-Tidal device accurately measures the volume of air exchanged during normal breathing and provides valuable information concerning lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, introduced N-Tidal, which is a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. This technology integrates N-Tidal’s CO2 sensor data with an artificial intelligence platform to gauge changes in lung function, seeking to improve the diagnosis and management of this respiratory condition. Clinical studies have shown the technology’s high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch represents a significant development in the application of AI for respiratory disease assessment, providing a more comfortable and efficient alternative to existing diagnostic tests.

Which Major Players Dominate The Artificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd

Read the full artificial intelligence (ai) in respiratory diseases market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Region Is Forecast To Lead The Artificial Intelligence (AI) In Respiratory Diseases Market In Terms Of Market Size?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In Respiratory Diseases Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Ai In Medical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Artificial Intelligence Ai In Animal Health Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-animal-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model